An exceptional group of non-small cell lung cancer difficult to diagnose: Evaluation of lipid-poor adrenal lesions

dc.contributor.authorSimsek, Fikri Selcuk
dc.contributor.authorArslan, Muhammet
dc.contributor.authorDag, Yusuf
dc.date.accessioned2026-08-12T16:41:53Z
dc.date.issued2019
dc.departmentFırat Üniversitesi
dc.description.abstractIn some non-small cell lung cancer (NSCLC) patients, lipid-poor adrenal adenomas cannot be adequately differentiated from metastases using imaging methods. Invasive diagnostic procedures also have a low negative predictive value (NPV) in such cases. The current study aims to establish a specific and clinically practical metabolic parameter for lipid-poor adrenal lesions (ALs) in NSCLC patients. This diagnostic approach may prevent unnecessary abdominal enhanced computed tomography (CT), magnetic resonance imaging, or invasive diagnostic procedures. Sixty-four NSCLC patients with 69 lipid-poor ALs and 28 control patients with 30 benign lipid-poor ALs, who underwent FDG-PET/CT, were retrospectively reviewed. Two morphological and four metabolic parameters were analyzed in FDG-PET/CT images of NSCLC and control patients. Baseline and post-chemotherapy images of 64 NSCLC patients were re-evaluated according to the PERCIST 1.0. In cases where ALs could not be differentiated, follow-up FDG-PET/CT images were re-examined. The receiver operating characteristic (ROC) curve method was used for the evaluation of diagnostic parameters. Out of 69 ALs, 39 were determined as metastatic lesions (adrenal metastasis), while 30 lesions were considered non-metastatic (adrenal adenomas). The mean attenuation value, SUVmax AL/SUVmax primary tumor, SUVmax, SUVmax AL/liver, and SUVmax AL/SUVmean liver were significantly different between metastatic and benign ALs from NSCLC patients. The SUVmax AL/SUVmean liver >= 1.81 had the best positive (PPV, 94.3%) and negative (NPV, 82.4%) predictive values, and the highest specificity (93.3%), sensitivity (84.6%) and accuracy (86.9%). Lipid-poor ALs with SUVmax AL/SUVmean liver >= 1.81 can be accepted as malignant in NSCLC. However, if SUVmax AL/SUVmean liver is <1.81, a pathologic examination is required. Utilizing this cut-off value to decide on adrenal core biopsy may prevent its unnecessary use. Moreover, this diagnostic approach can save time and reduce the healthcare costs.
dc.identifier.doi10.17305/bjbms.2019.3837
dc.identifier.endpage200
dc.identifier.issn1512-8601
dc.identifier.issn1840-4812
dc.identifier.issue2
dc.identifier.pmid30997878
dc.identifier.scopus2-s2.0-85066513215
dc.identifier.scopusqualityN/A
dc.identifier.startpage195
dc.identifier.urihttps://doi.org/10.17305/bjbms.2019.3837
dc.identifier.urihttps://hdl.handle.net/11508/46027
dc.identifier.volume19
dc.identifier.wosWOS:000468754400011
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAssoc Basic Medical Sci Federation Bosnia & Herzegovina Sarajevo
dc.relation.ispartofBosnian Journal of Basic Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectNSCLC
dc.subjectadrenal lesion
dc.subjectlipid-poor
dc.subject18F-FDG-PET/CT
dc.subjectdiagnostic difficulties
dc.titleAn exceptional group of non-small cell lung cancer difficult to diagnose: Evaluation of lipid-poor adrenal lesions
dc.typeArticle

Dosyalar